» Articles » PMID: 39092216

Nutrient Vitamins Enabled Metabolic Regulation of Ferroptosis Via Reactive Oxygen Species Biology

Overview
Journal Front Pharmacol
Date 2024 Aug 2
PMID 39092216
Authors
Affiliations
Soon will be listed here.
Abstract

Vitamins are dietary components necessary for cellular metabolic balance, especially redox homeostasis; deficient or excessive supply may give rise to symptoms of psychiatric disorders. Exploring the nutritional and metabolic pathways of vitamins could contribute to uncovering the underlying pathogenesis of ferroptosis-associated diseases. This mini-review aims to provide insights into vitamins closely linked to the regulation of ferroptosis from the perspective of cellular reactive oxygen species biology. The mainstream reprogramming mechanisms of ferroptosis are overviewed, focusing on unique biological processes of iron metabolism, lipid metabolism, and amino acid metabolism. Moreover, recent breakthroughs in therapeutic interventions targeting ferroptosis via fully utilizing vitamin-based pharmacological tools were overviewed, covering vitamins (B, C, E, and K). Finally, mechanism insight related to vitamin-associated nutrient signaling was provided, highlighting the pharmacological benefits of metabolically reprogramming ferroptosis-associated diseases.

Citing Articles

Recent Advances in Glutathione Depletion-Enhanced Porphyrin-Based nMOFs for Photodynamic Therapy.

Gong B, Zhang Q, Chen J, Qu Y, Luo X, Wang W Pharmaceutics. 2025; 17(2).

PMID: 40006611 PMC: 11860060. DOI: 10.3390/pharmaceutics17020244.


Mechanisms of Vitamins Inhibiting Ferroptosis.

Zhang M, Chen X, Zhang Y Antioxidants (Basel). 2025; 13(12.

PMID: 39765898 PMC: 11673384. DOI: 10.3390/antiox13121571.


Recent advances in cell membrane-coated porphyrin-based nanoscale MOFs for enhanced photodynamic therapy.

Zou Y, Wu J, Zhang Q, Chen J, Luo X, Qu Y Front Pharmacol. 2024; 15:1505212.

PMID: 39697550 PMC: 11652162. DOI: 10.3389/fphar.2024.1505212.


Porphyrin-engineered nanoscale metal-organic frameworks: enhancing photodynamic therapy and ferroptosis in oncology.

Zou Y, Chen J, Luo X, Qu Y, Zhou M, Xia R Front Pharmacol. 2024; 15:1481168.

PMID: 39512824 PMC: 11541831. DOI: 10.3389/fphar.2024.1481168.

References
1.
Liang C, Zhang X, Yang M, Dong X . Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019; 31(51):e1904197. DOI: 10.1002/adma.201904197. View

2.
Koppula P, Zhang Y, Zhuang L, Gan B . Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018; 38(1):12. PMC: 5993148. DOI: 10.1186/s40880-018-0288-x. View

3.
Bao W, Pang P, Zhou X, Hu F, Xiong W, Chen K . Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease. Cell Death Differ. 2021; 28(5):1548-1562. PMC: 8166828. DOI: 10.1038/s41418-020-00685-9. View

4.
Fei J, Dai L, Gao F, Zhao J, Li J . Assembled Vitamin B2 Nanocrystals with Optical Waveguiding and Photosensitizing Properties for Potential Biomedical Application. Angew Chem Int Ed Engl. 2019; 58(22):7254-7258. DOI: 10.1002/anie.201900124. View

5.
Gan H, Huang X, Luo X, Li J, Mo B, Cheng L . A Mitochondria-Targeted Ferroptosis Inducer Activated by Glutathione-Responsive Imaging and Depletion for Triple Negative Breast Cancer Theranostics. Adv Healthc Mater. 2023; 12(22):e2300220. DOI: 10.1002/adhm.202300220. View